Back

Anti-Xa/APTT discrepancy in heparinized ImpellaTM-supported cardiogenic shock patients can predict mortality

8 March 2024 (08:30 - 13:45)
Organised by: Logo
Congress Presentation Part of: Best practices in temporary mechanical circulatory support Cardiac Care Unit (CCU), Intensive, and Critical Cardiovascular Care ACVC Premium Access ESC Acute CardioVascular Care 2024 Association for Acute CardioVascular Care (ACVC)

About the speaker

Photo
Doctor Charlotte Van Edom

KU Leuven, Leuven (Belgium)

7 More presentations in this session

Presentation thumbnail
European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: an international survey of the ACVC Association of the ESC joint with EuroELSO
Doctor C. Van Edom (Leuven, BE)
Abstract Slides
Presentation thumbnail
Echocardiographic evaluation of ventricular performance in VA-ECMO weaning: results from a observational multicentric prospective study
Doctor V. Dammassa (London, GB)
Abstract Slides
Presentation thumbnail
Impact of early administration of beta-blocker and RAS inhibitor during VA-ECMO treatment for cardiogenic shock; the post-hoc study of the EARLY-UNLOAD trial.
Doctor S. Park (Kwang Ju, KR)
Abstract Slides
Presentation thumbnail
Impella vs Veno-arterial extracorporeal membrane oxygenation in cardiogenic shock: a systematic review and meta-analysis of propensity score matched studies
Professor D. Stub (Melbourne, AU)
Abstract Slides
Presentation thumbnail
Venoarterial ECMO in cardiogenic shock: a decade-long single-center analysis
Doctor M. Leite (Porto, PT)
Abstract Slides

Access the full session

Session thumbnail
Best practices in temporary mechanical circulatory support

The Event

Event poster

ESC Acute CardioVascular Care 2024

8 March - 10 March 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources